(2020). The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.
Chicago Style (17th ed.) CitationThe Inhibition of IL-2/IL-2R Gives Rise to CD8+ T Cell and Lymphocyte Decrease Through JAK1-STAT5 in Critical Patients with COVID-19 Pneumonia. 2020.
MLA (8th ed.) CitationThe Inhibition of IL-2/IL-2R Gives Rise to CD8+ T Cell and Lymphocyte Decrease Through JAK1-STAT5 in Critical Patients with COVID-19 Pneumonia. 2020.
Warning: These citations may not always be 100% accurate.